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SHORT COMMUNICATION
Upregulation of HLA-E by dengue and not Zika viruses
Elena Drews1, Awadalkareem Adam2, Phone Htoo2, Elizabeth Townsley1 & Anuja Mathew1,2
1Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA
2Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island,
Providence, RI, USA
Correspondence
A Mathew, Department of Cell and
Molecular Biology, Institute for Immunology
and Informatics, University of Rhode Island,
Room 334B, 80 Washington Street,
Providence, RI 02903, USA.
E-mail: mathewa@uri.edu
Received 19 March 2018;
Revised 7 August 2018;
Accepted 24 August 2018
doi: 10.1002/cti2.1039
Clinical & Translational Immunology
2018; 7: e1039
Abstract
Introduction. The most severe form of dengue virus (DENV) illness,
dengue haemorrhagic fever, is characterised by plasma leakage
and increased vascular permeability. Objectives. Given the critical
role that endothelial cells play in the pathogenesis of DENV, we
wanted to determine whether infection with DENV altered the
expression of MHC class I related genes including HLA-E. Results.
In this study, we provide evidence that HLA-E but not MICA/B or
HLA-G is upregulated by all four serotypes of DENV in an
endothelial cell line human microvascular endothelial cells
(HMEC)-1. In contrast, Zika virus (ZIKV), a related flavivirus, where
plasma leakage is not a major manifestation of disease, did not
upregulate HLA-E. We found modest levels of soluble HLA-E in
supernatants from DENV but not ZIKV-infected cells. Coculture
experiments found minimal activation of natural killer (NK) cells in
the presence of both uninfected and infected HMEC-1 cells. HLA-E
induced by DENV infection could not dampen the degranulation
of activated NK cells by interacting with its ligand NKG2a.
Conclusions. Our results suggest that while DENV infection
induces HLA-E, the high MHC class I expression on uninfected and
infected HMEC-1 cells may dominate the diverse signals generated
between inhibitory and activating receptors on NK cells and
ligands on target cells.
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INTRODUCTION
Endothelial cells (ECs) are an essential component
of the endothelial barrier and play a role in
homoeostasis, cell trafficking from the blood to
tissues and initiation of both inflammation and
the immune response. A hallmark of severe
dengue virus (DENV)-induced disease, dengue
haemorrhagic fever (DHF), is vascular leakage.1
The transient nature of plasma leakage during
DHF2 and the absence of strong evidence to
indicate direct infection of ECs with DENV in vivo
in human autopsy studies3 suggest that dengue
viral products and immune activators elicited by
DENV infection in many cells of the innate and
adaptive immune system impact EC function.1 In
vitro, DENV infects many kinds of ECs and
upregulates VCAM and ICAM on the cell surface.
A number of cytokines such as IL-6, IL-8 and IFNs
are elicited in response to infection.4 A focus of
many dengue researchers is to understand altered
endothelial function by immune activators and
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DENV products and identify important
contributors to the plasma leakage seen in DHF.5,6
Endothelial cells are not considered professional
antigen-presenting cells since they express a
limited number of costimulatory molecules;
however, they express MHC class I and II and can
present antigens to T cells.7 In addition to classical
MHC molecules, ECs also express class I related
genes MHC class I polypeptide-related sequence A
(MICA), the nonclassical MHC-Ib molecule, HLA-E
and the endothelial protein C receptor (EPCR).7
These molecules have been recently shown to be
important for the regulation and control of
infectious agents but whether they provide the
endothelium selective functions in response to
infection with DENV is unknown.7 MICA proteins
are constitutively expressed on the surface of ECs
and antigen-presenting cells.7 There is genetic
evidence to suggest that MICB is a susceptibility
locus for severe dengue.8,9 Soluble MICB levels
were found to be elevated in patients with acute
DENV infections.10 HLA-E belongs to the
nonclassical group of MHC-Ib molecules, which
include HLA-E, HLA-F and HLA-G in humans, and
has been mapped between the HLA-C and HLA-A
loci on the short arm of chromosome 6.11 HLA-E
binds peptides predominantly from signal
sequences of HLA-A, -B, -C and -G, and the surface
expression of HLA-E is influenced by the pattern
of HLA expressed in the cell that provides signal
peptides. HLA-E complexed with peptides from
some viral infections (cytomegalovirus, Epstein–
Barr virus) and bacterial infections
(Mycobacterium tuberculosis and Salmonella
typhimurium) can interact with T-cell receptors
(TCRs) expressed on CD8 T cells to trigger
conventional CTL function.12
Natural killer (NK) cells are regulated by many
activating and inhibitory receptors including two
major families, killer-like immunoglobulin
receptors (KIRs) and C-type lectin family of
receptors CD94 that interact with NKG2.13 KIRs
interact with classical MHC molecules, while the
inhibitory receptor CD94/NKG2a and the
activating receptor CD94/NKG2c, present on NK
cells and a subset of T cells, interact with HLA-E.14
HLA-E was recently shown to be upregulated by
Japanese encephalitis virus (JEV) infection in
human brain microvascular ECs, the endothelial-
like cell line, ECV 304 and human foreskin
fibroblasts.15,16 Antibodies to TNF and IFNR were
able to inhibit the secretion of soluble HLA-E
(sHLA-E) indicating a role for soluble factors/
cytokines in the shedding process. The soluble
HLA-E released from infected cells inhibited IL-2
and PMA-mediated ERK 1/2 phosphorylation in
two NK cell lines suggesting that HLA-E could be
involved in viral evasion of NK cell responses.16
RESULTS AND DISCUSSION
Upregulation of HLA class I and HLA-E
molecules on DENV-infected HMEC-1 cells
We evaluated an endothelial cell line of dermal
origin, human microvascular endothelial cells
(HMEC)-1, for the ability to support DENV
infection. We infected HMEC-1 cells with a
laboratory strain of DENV-2 (MOI = 1 and 10) and
assessed the infectivity and the expression of
classical MHC molecules and related class I
molecules on the cell surface using flow
cytometry. Expression of MHC class I molecules on
HMEC-1 cells was high, and it was further
upregulated after DENV infection as has been
reported previously17 using the pan HLA class I
specific mAb W6/32 (Figure 1a). We found no
expression of HLA-G and MICA/B on HMEC-1 cells
(Figure 1b, c) but in contrast, HLA-E was
significantly upregulated (Figure 1d) following
infection with DENV-2. UV-inactivated DENV-2 did
not change the expression of HLA-E suggesting
that active replication was needed for its
induction. All four serotypes of DENV upregulated
HLA-E on HMEC-1 cells (Figure 1e). Peak
expression was detected 48–72 h postinfection
(Figure 1f) with some variation among serotypes
and strains of DENV (data not shown). In contrast,
Zika virus (ZIKV), a related flavivirus that does not
induce significant plasma leakage, did not
upregulate HLA-E (Figure 1g).
We were interested to know whether HLA-E was
expressed on DENV-infected cells or bystander
HMEC-1 cells. We first infected two susceptible cell
lines with DENV-U937 expressing DC-SIGN, and
Huh 7. As expected, we found significant infection
of these cells by flow cytometry using the well-
characterised monoclonal antibody 2H2 which
recognises the premembrane (prM) protein of
DENV.17,18 However, while we found significant
infection in Huh7 and U937 DC-SIGN cells (50–70%
2H2+ cells), there was no upregulation of HLA-E
48 h postinfection (Figure 2a, b). In contrast,
HMEC-1 cells infected with DENV (MOI = 1) were
poorly infected (approximately 3.66% 2H2+ cells),
while over 60% cells upregulated HLA-E, 48 h
2018 | Vol. 7 | e1039
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postinfection. At a higher MOI (MOI = 10), we
were easily able to detect 2H2+ HMEC-1 cells but
most of the HLA-E upregulation was detected on
bystander cells and not virally infected (2H2+) cells
(Figure 2c). UV-inactivated DENV neither increased
viral infection nor upregulated HLA-E in HMEC-1
cells. The present observations suggest that DENV
but not ZIKV upregulates the nonclassical MHC
molecule HLA-E but not HLA-G, MICA or B in
HMEC-1 cells. As HLA-E is dependent on signal
sequences from HLA class I molecules for its
expression,19 it is possible that DENV-induced
Figure 1. Upregulation of HLA-E following DENV infection of HMEC-1 cells. HMEC-1 cells were infected with live or UV-inactivated DENV-2
NGC at the indicated MOIs and stained for the cell surface expression of (a) MHC-1, (b) HLA-G, (c) MICA-/B and (d) HLA-E. HLA-E expression
with (e) different serotypes of DENV (MOI = 1), (f) different times postinfection with DENV-3 and with (g) ZIKV at the indicated MOIs. Analysis
was performed 48 h postinfection. Data shown are representative of one of five experiments performed. DENV, dengue virus; HMEC-1, human
microvascular endothelial cells-1; ZIKV, Zika virus.
ª 2018 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
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expression of HLA-E is mediated through an
indirect mechanism since class I is also upregulated
in these cells. Our data also support soluble factors
induced by DENV infection being responsible for
the increased expression of HLA-E on bystander
HMEC-1 cells as has been shown recently for JEV.15
Figure 2. Upregulation of HLA-E on susceptible cell lines. Flow cytometric analysis of (a) U937 DC-SIGN (b) Huh7 and (c) HMEC-1 cells infected
with DENV at the indicated MOIs, 48 h postinfection. Cells were stained for HLA-E, permeabilised and assessed for DENV infection using a
labelled antibody 2H2 directed against the prM protein of DENV. Data are representative of one of three experiments performed. (d) ELISA for
sHLA-E using cell culture supernatants from DENV-2-infected HMEC-1 cells at the indicated time points and MOIs. DENV, dengue virus; HMEC-1,
human microvascular endothelial cells-1.
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DENV induces moderate levels of soluble
HLA-E
The functional significance of sHLA-E molecules is
still poorly understood especially in the context
of viral evasion of immune responses.20 Low levels
of sHLA-E have been detected in the plasma of
patients with chronic HBV.21 HLA-E released from
JEV-infected cells blocked IL-2-mediated
phosphorylation of ERK1/2 in the human NK cell
lines suggesting that sHLA-E could play a role in
the regulation of immune responses.16
We infected HMEC cells with all four serotypes
of DENV and collected supernatants at different
times point postinfection. Supernatants from
HMEC-1 cells infected with DENV-2 had low levels
of sHLA-E compared to supernatants from
uninfected HMEC-1 cells with peak expression
detected at 24 h (Figure 2d). Supernatants from
cells infected with the other three DENV serotypes
and ZIKV also had low levels of sHLA-E (data not
shown). In contrast to JEV infection,15,16 we found
robust expression of HLA-E on the cell surface and
minimal to moderate levels of sHLA-E in
supernatants of infected HMEC-1 cells.
HLA-E expressed on HMEC-1 cells following
DENV infection does not modulate NK cell
function
To determine whether there was a functional
consequence of HLA-E upregulation on the
surface of HMEC-1 cells following DENV infection,
we measured the degranulation of NK cells using
the marker CD107a and IFN-c intracellular
expression in coculture experiments. We used an
NK cell line, NK92 known to express NKG2a, the
well-recognised inhibitory ligand of HLA-E.14 We
added NK92 cells in media to HMEC-1 cells that
were either uninfected or infected 24 h prior with
DENV. We found minimal degranulation of
CD107a and IFN-c expression in NK92 cells that
were incubated with either uninfected or DENV-
infected HMEC cells (Figure 3a, b) which is in
contrast to findings by Siren et al. 22 who
reported influenza and Sendai virus-infected
macrophages induced IFN-c gene expression and
protein production in NK92 cells. We speculate
that the high expression of class I (known to
dampen NK cell responses) on HMEC-1 cells, which
was further upregulated by DENV infection, may
have provided a strong inhibitory signal to NK92
cells thus preventing their activation.
Since NK cells are known to be activated in
PBMC from patients undergoing acute dengue
infections,23,24 we stimulated NK92 cells with
PMA + Ionomycin known to upregulate CD107 and
IFN-c expression (Figure 3c, d). We asked
whether HLA-E induced by DENV infection in HMEC-
1 cells could attenuate IFN-c production and the
degranulation of activated NK92 cells in our
coculture system. Unexpectedly, we found no
difference in CD107 degranulation in activated
NK92 cells added to infected or uninfected HMEC
cells (Figure 3e, f). Instead, IFN-c expression was
increased in the presence of infected HMEC cells. To
determine whether the increase in IFN-c expression
was dependent on HLA-E, we used an antibody to
block HLA-E and we found a similar increase in IFN-c
expression under these conditions. These results
indicate to us that HLA-E induced by DENV infection
in HMEC cells was not responsible for the increased
IFN-c expression in NK92 cells (Figure 3g).
Using our coculture conditions, the cytolytic
activity and cytokine expression in NK92 cells
expressing the inhibitory receptor NKG2a was not
affected by HLA-E upregulation on HMEC-1 cells.
NK cells expressing the inhibitory (NKG2a) and
activating (NKG2c) ligands for HLA-E have recently
been shown to be upregulated on NK cells during
acute DENV infection.25 Additional studies are
required to determine whether NKG2c+ NK cells
are impacted by HLA-E expression on ECs.
Furthermore, how NK cells respond to ligands
including HLA-E following DENV infection of
other target cells such as primary dendritic cells
and monocytes may differ from responses to ECs
and are worthy of future study.
METHODS
Passage and infection of cell lines
HMEC-1 cells were grown in MDCB 131 media
(ThermoFisher Scientific, Waltham, MA, USA) with 10%
FBS, supplemented with 10 ng mL1 epidermal growth
factor and 1 lg mL1 hydrocortisone and passaged in T75
flasks. For infections, HMEC-1 cells were trypsinised with
1:4 diluted trypsin/EDTA and 1.5 9 105 HMEC-1 cells were
plated on 12-well tissue culture plates. HMEC-1 cells were
infected with different strains of DENV (DENV-1 Hawaii,
DENV-2 NGC, DENV-3 CH53489 and DENV-4 814669) at the
indicated multiplicity of infection (MOI). Huh7 cells were
grown in DMEM media (Mediatech Inc., Manassas, VA,
USA) with 10% FBS. U937 DC-SIGN cells were grown in
RPMI 1640 media with 10% FBS (Sigma-Aldrich, St Louis,
MO, USA). Cells were incubated with DENV in 250 lL for
90 min. After infection, 750 lL of the indicated media was
ª 2018 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
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added, and infected HMEC-1 was incubated at 37°C in 5%
CO2 for 48 h.
Staining for class I related molecules and
DENV
Uninfected and infected HMEC-1 and Huh 7 cells were
trypsinised and washed in fluorescence activated cell
sorting buffer (PBS/2%FBS/0.1% sodium azide). HMEC-1,
U937 DC-SIGN and Huh 7 cells were stained with an
antibody to HLA-E (clone 3D12), HLA-G (clone 87G),
MICA/B (clone 6D4) for 20 min, washed and permeabilised
in 200 lL Cytofix/Cytoperm (BD Biosciences, San Jose, CA,
USA) for 20 min at room temperature. Cells were washed
in 19 Perm Wash buffer (BD Biosciences) and stained
with DL650 labelled DENV-specific antibody 2H2 for
30 min.
Soluble HLA-E ELISA
HMEC-1 cells were infected with at the indicated MOIs. Culture
supernatants were collected after 24, 48 and 72 h, spun at
MEDIA
PMA + IONO
HMEC
INF. HMEC
HMEC
PMA + IONO
INF. HMEC
PMA + IONO
INF. HMEC
PMA + IONO
anti HLA-E
(c)
(d)
(a)
(b)
(e)
(f)
(g)
(h)
CD107 IFN-γ
CD107 IFN-γ
HLA-E
Figure 3. Degranulation and cytokine production by NK92 cells. (a and b) NK92 cells were unstimulated or stimulated with PMA + Iono. NK92 cells
were added to HMEC-1 cells that were (c and e) uninfected or (d, f and g) infected approximately 30 h prior with DENV-4 (MOI = 10). CD107a
degranulation and IFN-c expression in NK92 cells were assessed following no stimulation or stimulation with PMA + Iono for approximately 18 h in
the presence of Golgi Stop and Plug. (g) Anti-HLA-E antibody was added at 5 lg mL1 24 h postinfection. Data are representative of one of two
experiments performed. (h) Histogram of HLA-E expression on uninfected (filled dark grey histogram), infected (open solid histogram), infected cells
treated with anti-HLA-E (filled light grey histogram) or control antibody (open dotted histogram). DENV, dengue virus; HMEC-1, human microvascular
endothelial cells-1; NK, natural killer.
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845 g for 10 min, and stored at 80°C. Human leucocyte
antigen E (HLA-E) ELISA was performed on cell culture
supernatants according to manufacturer’s instructions using an
ELISA kit from TSZ ELISA. A serial standard was used to create a
standard curve that ranged from 3.12 to 200 U mL1. Each
sample was tested in duplicates.
Degranulation and cytokine assay
NK92 cells (2.5 9 105) grown in specialised media and
maintained as described26 were added to HMEC-1 cells
grown in 12-well plates that were either uninfected or
infected with DENV approximately 30 h prior. PMA
(100 ng mL1) + Ionomycin (50 ng mL1) (PMA + Iono) was
added to the indicated wells. CD107 antibody (clone H4A3)
was added to wells containing NK92 cells. After 1 h, Golgi Stop
and Plug was added. After 18 h, NK92 cells were removed
from the plate and stained for CD56 (clone HCD56), NKG2A
(clone Z199) and intracellular expression of IFN-c (clone B27).
In experiments where we blocked HLA-E expression, 5-
10 lg mL1 of anti-HLA-E was added to the indicated wells
24 h postinfection. Data were collected on a BD LSR and
analysed using FlowJo version X software (Tree Star Inc,
Ashland, OR, USA).
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